Form 4: Baker Bros. Advisors Report Immunocore Holdings Transactions, Disgorge Short-Swing Profits

Sentiment:

SEC Form 4


Baker Bros. Advisors and related entities report transactions in Immunocore Holdings plc securities, including purchases of American Depositary Shares (ADS) and sales of convertible notes, while also agreeing to disgorge short-swing profits.

Summary

  • Baker Bros. Advisors LP and related entities, including Julian and Felix Baker, filed a Form 4 detailing transactions in Immunocore Holdings plc (IMCR) securities.
  • The transactions include purchases of Immunocore's American Depositary Shares (ADS) at prices around $29.56 to $29.74 on March 17, 2025.
  • They also involve the sale of 2.5% Convertible Senior Notes due 2030.
  • The reporting persons realized short-swing profits under Section 16(b) of the Exchange Act and agreed to disgorge $25,314.67 to Immunocore Holdings plc.
  • The filers disclaim beneficial ownership of the securities held by the Funds except to the extent of their pecuniary interest.
  • Ranjeev Krishana, an employee of Baker Bros. Advisors LP, is a director of Immunocore Holdings plc, leading to the reporting persons being deemed directors by deputization.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document primarily reports transactions and a regulatory compliance matter. The disgorgement of profits is a negative, but the filing itself is a standard procedure.

Negatives

  • The reporting persons realized short-swing profits and had to disgorge $25,314.67, indicating a potential compliance oversight.

Risks

  • The 2.5% Convertible Notes are subject to a beneficial ownership limitation, which could restrict the extent of conversion.
  • The reporting persons' beneficial ownership is disclaimed except to the extent of their pecuniary interest, which could create uncertainty regarding their influence.

Future Outlook

The document does not contain specific forward-looking statements regarding Immunocore's future performance.

Industry Context

Form 4 filings are standard practice for reporting transactions by company insiders and major shareholders, providing transparency to the market.

Comparison to Industry Standards

  • Form 4 filings are a standard regulatory requirement for insiders and major shareholders in publicly traded companies, ensuring transparency in trading activities.
  • The disgorgement of short-swing profits is also a common occurrence when insiders violate Section 16(b) of the Securities Exchange Act, which aims to prevent the misuse of non-public information.

Stakeholder Impact

  • Shareholders are informed about the transactions of major shareholders, providing transparency.
  • The disgorgement of short-swing profits benefits the company by returning funds obtained through potentially unfair trading practices.

Key Dates

DateDescription
08/01/2024Beginning date for semi-annual interest payments on the 2.5% Convertible Senior Notes.
03/17/2025Date of the reported transactions, including purchases of ADS and sales of convertible notes.
03/19/2025Date of the signatures on the Form 4 filing and agreement to disgorge short-swing profits.
02/01/2030Maturity date of the 2.5% Convertible Senior Notes.

Keywords

Immunocore Holdings, Baker Bros. Advisors, ADS, Convertible Notes, Form 4, Short-Swing Profits, Beneficial Ownership, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.